| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
8,358 |
1,717 |
$294K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,892 |
1,677 |
$217K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,448 |
1,318 |
$128K |
| 80053 |
Comprehensive metabolic panel |
9,252 |
7,678 |
$125K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,519 |
3,640 |
$103K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,626 |
2,465 |
$79K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
9,433 |
7,839 |
$73K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,237 |
1,102 |
$48K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,138 |
3,498 |
$48K |
| 71045 |
Radiologic examination, chest; single view |
4,335 |
3,778 |
$38K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,282 |
1,085 |
$35K |
| 83880 |
|
1,490 |
1,274 |
$30K |
| 84484 |
|
3,365 |
2,613 |
$30K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
312 |
258 |
$30K |
| 83874 |
|
2,515 |
2,002 |
$30K |
| 87400 |
|
4,051 |
2,506 |
$29K |
| 82553 |
|
2,511 |
2,001 |
$29K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,041 |
2,258 |
$26K |
| 36415 |
Collection of venous blood by venipuncture |
10,016 |
7,512 |
$25K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,123 |
1,945 |
$25K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
675 |
539 |
$25K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,280 |
1,207 |
$22K |
| 81001 |
|
5,535 |
4,713 |
$20K |
| 82550 |
|
2,574 |
2,082 |
$19K |
| 94760 |
|
1,554 |
1,256 |
$18K |
| 87081 |
|
1,816 |
1,671 |
$16K |
| 71046 |
Radiologic examination, chest; 2 views |
723 |
643 |
$14K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
69 |
64 |
$13K |
| 80305 |
|
1,099 |
948 |
$13K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,891 |
1,648 |
$12K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
120 |
111 |
$11K |
| 97162 |
|
95 |
83 |
$10K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
232 |
161 |
$9K |
| 87428 |
|
165 |
143 |
$8K |
| 87040 |
|
975 |
531 |
$8K |
| T1015 |
Clinic visit/encounter, all-inclusive |
582 |
517 |
$8K |
| 83605 |
|
780 |
656 |
$7K |
| 84443 |
Thyroid stimulating hormone (TSH) |
475 |
419 |
$7K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
960 |
831 |
$6K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
720 |
609 |
$6K |
| 85027 |
|
1,355 |
1,117 |
$5K |
| 83690 |
|
668 |
609 |
$5K |
| 81025 |
|
636 |
563 |
$5K |
| 87077 |
|
712 |
565 |
$4K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
27 |
13 |
$4K |
| 80061 |
Lipid panel |
577 |
517 |
$3K |
| 86756 |
|
195 |
179 |
$3K |
| 83735 |
|
570 |
489 |
$3K |
| 87186 |
|
699 |
555 |
$3K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
64 |
36 |
$3K |
| 73562 |
|
72 |
57 |
$3K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
41 |
38 |
$3K |
| 85610 |
|
951 |
679 |
$3K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
12 |
12 |
$2K |
| 82150 |
|
250 |
236 |
$2K |
| 82962 |
|
461 |
237 |
$2K |
| 71020 |
|
130 |
119 |
$2K |
| 86140 |
|
317 |
267 |
$2K |
| 71010 |
|
252 |
233 |
$1K |
| M0239 |
Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring |
17 |
16 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
385 |
330 |
$1K |
| 97001 |
|
32 |
29 |
$1K |
| 97161 |
|
13 |
12 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
176 |
159 |
$1K |
| 85379 |
|
99 |
93 |
$1K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
26 |
25 |
$1K |
| 73030 |
|
40 |
38 |
$958.76 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
27 |
27 |
$780.31 |
| 73630 |
|
29 |
26 |
$739.20 |
| 85730 |
|
141 |
123 |
$684.31 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
28 |
26 |
$425.80 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
46 |
41 |
$400.53 |
| 82803 |
|
17 |
12 |
$291.41 |
| 80320 |
|
16 |
12 |
$211.53 |
| 73610 |
|
13 |
13 |
$209.70 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
19 |
19 |
$207.64 |
| 90715 |
|
30 |
29 |
$203.97 |
| 82565 |
|
26 |
15 |
$176.55 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17 |
16 |
$158.29 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
13 |
13 |
$93.52 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
47 |
13 |
$57.56 |
| 36416 |
|
63 |
47 |
$53.73 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
93 |
52 |
$39.15 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
577 |
508 |
$7.73 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
54 |
53 |
$0.00 |
| 90670 |
|
32 |
29 |
$0.00 |